Helga Simon‐Molas

575 total citations
18 papers, 389 citations indexed

About

Helga Simon‐Molas is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Helga Simon‐Molas has authored 18 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Helga Simon‐Molas's work include Chronic Lymphocytic Leukemia Research (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Pancreatic function and diabetes (4 papers). Helga Simon‐Molas is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Pancreatic function and diabetes (4 papers). Helga Simon‐Molas collaborates with scholars based in Netherlands, United States and Spain. Helga Simon‐Molas's co-authors include Ramón Bartrons, Àurea Navarro‐Sabaté, Esther Castaño, Ànna Manzano, Ana Rodríguez‐García, Pere Fontova, Francesc Ventura, José Luís Rosa, Ubaldo Martinez‐Outschoorn and Eric Eldering and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and FEBS Journal.

In The Last Decade

Helga Simon‐Molas

18 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helga Simon‐Molas Netherlands 7 252 201 87 60 57 18 389
Dongtao Fu United States 9 233 0.9× 159 0.8× 96 1.1× 53 0.9× 42 0.7× 16 407
Consuelo Torrini United States 6 321 1.3× 150 0.7× 60 0.7× 42 0.7× 65 1.1× 12 424
Ana Rodríguez‐García Spain 4 221 0.9× 186 0.9× 68 0.8× 45 0.8× 25 0.4× 7 319
Jue‐Yu Zhou China 15 426 1.7× 278 1.4× 110 1.3× 42 0.7× 38 0.7× 42 591
Chao Zhai China 5 265 1.1× 159 0.8× 73 0.8× 44 0.7× 80 1.4× 7 488
Nicole P. Ho Hong Kong 6 265 1.1× 213 1.1× 137 1.6× 65 1.1× 23 0.4× 9 453
Xuetao Li China 13 403 1.6× 311 1.5× 59 0.7× 45 0.8× 50 0.9× 20 543
Feda H. Hamdan United States 16 326 1.3× 103 0.5× 146 1.7× 54 0.9× 33 0.6× 25 507
Hwa-Ryeon Kim South Korea 10 259 1.0× 128 0.6× 92 1.1× 67 1.1× 24 0.4× 13 381

Countries citing papers authored by Helga Simon‐Molas

Since Specialization
Citations

This map shows the geographic impact of Helga Simon‐Molas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga Simon‐Molas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga Simon‐Molas more than expected).

Fields of papers citing papers by Helga Simon‐Molas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga Simon‐Molas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga Simon‐Molas. The network helps show where Helga Simon‐Molas may publish in the future.

Co-authorship network of co-authors of Helga Simon‐Molas

This figure shows the co-authorship network connecting the top 25 collaborators of Helga Simon‐Molas. A scholar is included among the top collaborators of Helga Simon‐Molas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helga Simon‐Molas. Helga Simon‐Molas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cretenet, Gaspard, Bauke V. Schomakers, Michel van Weeghel, et al.. (2025). Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia. Cellular and Molecular Immunology. 22(5). 485–500. 4 indexed citations
2.
Simon‐Molas, Helga, Melanie Mediavilla-Varela, Julio C. Chávez, et al.. (2025). Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model. Blood Advances. 9(10). 2511–2529. 3 indexed citations
3.
Simon‐Molas, Helga, et al.. (2025). Metabolic Profiling of Tumor and Immune Cells Integrating Seahorse and Flow Cytometry. Methods in molecular biology. 2930. 103–126. 1 indexed citations
4.
Derks, Ingrid A. M., et al.. (2024). Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies. iScience. 27(5). 109640–109640. 2 indexed citations
5.
Simon‐Molas, Helga, et al.. (2024). Metabolic reprogramming in the CLL TME; potential for new therapeutic targets. Seminars in Hematology. 61(3). 155–162. 2 indexed citations
6.
Simon‐Molas, Helga, et al.. (2023). Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways. Molecular Oncology. 18(7). 1777–1794. 4 indexed citations
7.
Cretenet, Gaspard, Bauke V. Schomakers, Michel van Weeghel, et al.. (2023). T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia. Blood Advances. 7(21). 6540–6552. 7 indexed citations
8.
Simon‐Molas, Helga, et al.. (2023). Multifactorial Basis of T Cell Dysfunction in CLL: Disrupted Mitochondrial Metabolism Induces T Cell Senescence. Blood. 142(Supplement 1). 4629–4629. 1 indexed citations
11.
Simon‐Molas, Helga, Gaspard Cretenet, Beatriz Valle‐Argos, et al.. (2022). Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood. 140(6). 630–643. 27 indexed citations
12.
Simon‐Molas, Helga, Cristina Sánchez‐de‐Diego, Àurea Navarro‐Sabaté, et al.. (2022). The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells. International Journal of Molecular Sciences. 23(3). 1905–1905. 10 indexed citations
13.
Simon‐Molas, Helga, Pere Fontova, Claudia Arnedo-Pac, et al.. (2021). TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A. International Journal of Molecular Sciences. 22(14). 7436–7436. 6 indexed citations
14.
Simon‐Molas, Helga, Gaspard Cretenet, Beatriz Valle‐Argos, et al.. (2021). Targeting Metabolic Alterations in CLL Microenvironment; Inhibition of Glutamine Import Attenuates Venetoclax Resistance. Blood. 138(Supplement 1). 3717–3717. 1 indexed citations
15.
Simon‐Molas, Helga, Claudia Arnedo-Pac, Pere Fontova, et al.. (2018). PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation. Molecular and Cellular Biochemistry. 448(1-2). 187–197. 21 indexed citations
16.
Bartrons, Ramón, Helga Simon‐Molas, Ana Rodríguez‐García, et al.. (2018). Fructose 2,6-Bisphosphate in Cancer Cell Metabolism. Frontiers in Oncology. 8. 331–331. 93 indexed citations
17.
Bartrons, Ramón, Ana Rodríguez‐García, Helga Simon‐Molas, et al.. (2018). The potential utility of PFKFB3 as a therapeutic target. Expert Opinion on Therapeutic Targets. 22(8). 659–674. 62 indexed citations
18.
Rodríguez‐García, Ana, Pere Fontova, Helga Simon‐Molas, et al.. (2017). TGF‐β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells. FEBS Journal. 284(20). 3437–3454. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026